A group of NIH physicians says Eli Lilly manipulated medical guidelines for treating sepsis, a blood infection, to promote use of its drug Xigris. Lilly said it is looking into the accusations but said it did not believe it had a role in the content of the guidelines beyond paying for the effort to draft guidelines.

Related Summaries